Pharmaceuticals: Major
Major Italian companies producing pharmaceuticals
Global pharmaceutical corporations develop and distribute prescription medications at a massive scale. Patent expirations, pipeline approvals, and healthcare legislation serve as major catalysts for trading activity and industry liquidity. Market data indicates that Recordati S.p.A. is currently the highest-volume asset, while Philogen SpA tops the 24-hour return list. The table below tracks the vital technical and fundamental metrics for these equities.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 4LLYEli Lilly and Company | 1.19 T EUR | 1,222.0 EUR | −2.86% | 0 | 0.00 | 45.48 | 26.87 EUR | +55.94% | 0.47% | Health technology | Strong buy |
 4JNJJohnson & Johnson | 592.45 B EUR | 244.95 EUR | −0.81% | 0 | 0.00 | 42.09 | 5.82 EUR | −34.10% | 1.91% | Health technology | Buy |
 4ABBVAbbVie, Inc. | 464.16 B EUR | 259.6 EUR | −1.18% | 0 | — | 50.61 | 5.13 EUR | +354.14% | 2.35% | Health technology | Buy |
 4MRKXMerck & Co., Inc. | 330.4 B EUR | 131.56 EUR | −1.82% | 100 | — | 152.20 | 0.86 EUR | −86.58% | 2.26% | Health technology | Buy |
 4PFEPfizer Inc. | 156.31 B EUR | 26.300 EUR | −3.31% | 0 | 0.00 | 42.61 | 0.62 EUR | −57.78% | 5.59% | Health technology | Neutral |
 4VRTXVertex Pharmaceuticals Incorporated | 123.98 B EUR | 490.00 EUR | +1.58% | 0 | — | 35.71 | 13.72 EUR | +13.49% | 0.00% | Health technology | Buy |
 4BMYBristol-Myers Squibb Company | 116.86 B EUR | 56.01 EUR | −1.70% | 0 | — | 14.06 | 3.98 EUR | +57.85% | 3.93% | Health technology | Buy |
 4SANSanofi SA | 100.88 B EUR | 83.51 EUR | −1.42% | 0 | 0.00 | 25.08 | 3.33 EUR | −35.60% | 4.90% | Health technology | Buy |
 4REGNRegeneron Pharmaceuticals, Inc. | 85.73 B EUR | 807.8 EUR | −1.54% | 0 | — | 20.20 | 39.99 EUR | +12.33% | 0.40% | Health technology | Buy |
 4MRKMerck KGaA | 65.41 B EUR | 148.70 EUR | −1.00% | 0 | — | 27.28 | 5.45 EUR | −17.22% | 1.46% | Health technology | Buy |
 4UCBUCB S.A. | 53.69 B EUR | 291.1 EUR | 0.00% | 0 | 0.00 | 25.75 | 11.31 EUR | +64.98% | 0.36% | Health technology | Buy |
 4BAYNBayer AG | 53.29 B EUR | 55.22 EUR | −1.81% | 30 | 0.08 | — | −1.77 EUR | +49.15% | 0.20% | Health technology | Buy |
 4BIIBBiogen Inc. | 33.5 B EUR | 222.25 EUR | −0.63% | 0 | — | 107.78 | 2.06 EUR | −77.93% | 0.00% | Health technology | Buy |
 4ZTSZoetis, Inc. Class A | 32.83 B EUR | 71.56 EUR | −4.18% | 0 | — | 13.44 | 5.32 EUR | +7.88% | 2.38% | Health technology | Neutral |
 4INCYIncyte Corporation | 22.3 B EUR | 106.35 EUR | −1.16% | 0 | — | 64.11 | 1.66 EUR | −67.34% | 0.00% | Health technology | Buy |
 4VTRSViatris, Inc. | 19.66 B EUR | 17.322 EUR | +1.33% | 0 | 0.00 | — | −0.31 EUR | +87.33% | 2.50% | Health technology | Buy |
 4ORNBVOrion Oyj Class B | 14.23 B EUR | 101.60 EUR | +0.40% | 0 | — | 21.71 | 4.68 EUR | +110.09% | 1.77% | Health technology | Neutral |
 RECRecordati S.p.A. | 10.96 B EUR | 53.25 EUR | +0.38% | 283.33 K | 0.65 | 22.37 | 2.38 EUR | +22.24% | 2.52% | Health technology | Neutral |
 4GRFGrifols, S.A. Class A | 6.67 B EUR | 11.185 EUR | −1.15% | 0 | — | 16.83 | 0.66 EUR | +51.93% | 1.68% | Health technology | Buy |
 4OGNOrganon & Co. | 3.23 B EUR | 12.258 EUR | −0.49% | 0 | — | 18.06 | 0.68 EUR | −58.61% | 0.58% | Health technology | Neutral |
 PHILPhilogen SpA | 611.18 M EUR | 21.15 EUR | +2.67% | 3.48 K | 0.37 | 3.79 | 5.58 EUR | +390.98% | 3.35% | Health technology | Buy |
 FFFine Foods & Pharmaceuticals N.T.M. SpA | 153.99 M EUR | 6.16 EUR | +0.98% | 22.12 K | 0.76 | — | −0.05 EUR | −110.39% | 2.54% | Health technology | Buy |
 4IPHInnate Pharma SA Class A | 140.07 M EUR | 1.272 EUR | +1.44% | 0 | — | — | −0.51 EUR | +7.91% | 0.00% | Health technology | Strong buy |